Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Ozurdex as an Treatment Option for Macula Edema Due to Irvine Gass Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01945892
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:26.520774+00:00
Published At
2013-09-19T00:00:00+00:00
Record Updated At
2013-09-19
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Macular Edema", "Visual Acuity"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-09-19"
protocolSection.identificationModule.nctId
"NCT01945892"
protocolSection.identificationModule.officialTitle
"Ozurdex as an Treatment Option for Macula Edema Due to Irvine Gass Syndrome"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Macular Edema (protocolSection.conditionsModule.conditions)
  • Visual Acuity (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.